Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

A vs DHR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
A
Agilent Technologies, Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$33.31B
5Y Perf.+33.5%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$123.80B
5Y Perf.+18.4%

A vs DHR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
A logoA
DHR logoDHR
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Market Cap$33.31B$123.80B
Revenue (TTM)$7.07B$24.78B
Net Income (TTM)$1.29B$3.69B
Gross Margin38.8%60.7%
Operating Margin20.6%21.0%
Forward P/E19.7x20.7x
Total Debt$3.35B$18.42B
Cash & Equiv.$1.79B$4.62B

A vs DHRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

A
DHR
StockMay 20May 26Return
Agilent Technologie… (A)100133.5+33.5%
Danaher Corporation (DHR)100118.4+18.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: A vs DHR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: A leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Danaher Corporation is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
A
Agilent Technologies, Inc.
The Income Pick

A carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 10 yrs, beta 1.23, yield 0.8%
  • Rev growth 6.7%, EPS growth 3.2%, 3Y rev CAGR 0.5%
  • PEG 1.34 vs DHR's 34.20
Best for: income & stability and growth exposure
DHR
Danaher Corporation
The Long-Run Compounder

DHR is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 218.0% 10Y total return vs A's 202.6%
  • Lower volatility, beta 0.94, Low D/E 35.1%, current ratio 1.87x
  • Beta 0.94 vs A's 1.23, lower leverage
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthA logoA6.7% revenue growth vs DHR's 2.9%
ValueA logoALower P/E (19.7x vs 20.7x), PEG 1.34 vs 34.20
Quality / MarginsA logoA18.3% margin vs DHR's 14.9%
Stability / SafetyDHR logoDHRBeta 0.94 vs A's 1.23, lower leverage
DividendsA logoA0.8% yield, 10-year raise streak, vs DHR's 0.7%
Momentum (1Y)A logoA+12.8% vs DHR's -7.2%
Efficiency (ROA)A logoA10.1% ROA vs DHR's 4.5%, ROIC 13.5% vs 5.9%

A vs DHR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AAgilent Technologies, Inc.
FY 2025
Agilent CrossLab
41.9%$2.9B
Life Sciences and Applied Markets
39.2%$2.7B
Applied Markets
18.9%$1.3B
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B

A vs DHR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALAGGINGDHR

Income & Cash Flow (Last 12 Months)

DHR leads this category, winning 4 of 6 comparable metrics.

DHR is the larger business by revenue, generating $24.8B annually — 3.5x A's $7.1B. Profitability is closely matched — net margins range from 18.3% (A) to 14.9% (DHR). On growth, A holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
RevenueTrailing 12 months$7.1B$24.8B
EBITDAEarnings before interest/tax$1.7B$7.2B
Net IncomeAfter-tax profit$1.3B$3.7B
Free Cash FlowCash after capex$993M$5.3B
Gross MarginGross profit ÷ Revenue+38.8%+60.7%
Operating MarginEBIT ÷ Revenue+20.6%+21.0%
Net MarginNet income ÷ Revenue+18.3%+14.9%
FCF MarginFCF ÷ Revenue+14.1%+21.4%
Rev. Growth (YoY)Latest quarter vs prior year+7.0%+3.7%
EPS Growth (YoY)Latest quarter vs prior year-3.6%+9.8%
DHR leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

A leads this category, winning 4 of 7 comparable metrics.

At 25.8x trailing earnings, A trades at a 26% valuation discount to DHR's 34.7x P/E. Adjusting for growth (PEG ratio), A offers better value at 1.75x vs DHR's 34.20x — a lower PEG means you pay less per unit of expected earnings growth.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
Market CapShares × price$33.3B$123.8B
Enterprise ValueMkt cap + debt − cash$34.9B$137.6B
Trailing P/EPrice ÷ TTM EPS25.75x34.71x
Forward P/EPrice ÷ next-FY EPS est.19.71x20.73x
PEG RatioP/E ÷ EPS growth rate1.75x34.20x
EV / EBITDAEnterprise value multiple19.74x18.14x
Price / SalesMarket cap ÷ Revenue4.79x5.04x
Price / BookPrice ÷ Book value/share4.96x2.37x
Price / FCFMarket cap ÷ FCF28.92x23.54x
A leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

A leads this category, winning 7 of 9 comparable metrics.

A delivers a 18.7% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $7 for DHR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to A's 0.50x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs A's 5/9, reflecting strong financial health.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
ROE (TTM)Return on equity+18.7%+7.1%
ROA (TTM)Return on assets+10.1%+4.5%
ROICReturn on invested capital+13.5%+5.9%
ROCEReturn on capital employed+14.5%+7.0%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.50x0.35x
Net DebtTotal debt minus cash$1.6B$13.8B
Cash & Equiv.Liquid assets$1.8B$4.6B
Total DebtShort + long-term debt$3.4B$18.4B
Interest CoverageEBIT ÷ Interest expense19.53x18.13x
A leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

A leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in A five years ago would be worth $9,234 today (with dividends reinvested), compared to $7,907 for DHR. Over the past 12 months, A leads with a +12.8% total return vs DHR's -7.2%. The 3-year compound annual growth rate (CAGR) favors A at -3.1% vs DHR's -5.6% — a key indicator of consistent wealth creation.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
YTD ReturnYear-to-date-14.3%-23.9%
1-Year ReturnPast 12 months+12.8%-7.2%
3-Year ReturnCumulative with dividends-9.0%-15.9%
5-Year ReturnCumulative with dividends-7.7%-20.9%
10-Year ReturnCumulative with dividends+202.6%+218.0%
CAGR (3Y)Annualised 3-year return-3.1%-5.6%
A leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — A and DHR each lead in 1 of 2 comparable metrics.

DHR is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than A's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
Beta (5Y)Sensitivity to S&P 5001.23x0.94x
52-Week HighHighest price in past year$160.27$242.80
52-Week LowLowest price in past year$104.36$172.06
% of 52W HighCurrent price vs 52-week peak+73.4%+72.0%
RSI (14)Momentum oscillator 0–10052.232.3
Avg Volume (50D)Average daily shares traded2.0M4.1M
Evenly matched — A and DHR each lead in 1 of 2 comparable metrics.

Analyst Outlook

A leads this category, winning 2 of 2 comparable metrics.

Wall Street rates A as "Buy" and DHR as "Buy". Consensus price targets imply 41.2% upside for DHR (target: $247) vs 41.0% for A (target: $166). For income investors, A offers the higher dividend yield at 0.84% vs DHR's 0.71%.

MetricA logoAAgilent Technolog…DHR logoDHRDanaher Corporati…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$166.00$247.00
# AnalystsCovering analysts3842
Dividend YieldAnnual dividend ÷ price+0.8%+0.7%
Dividend StreakConsecutive years of raises101
Dividend / ShareAnnual DPS$0.99$1.23
Buyback YieldShare repurchases ÷ mkt cap+1.3%+2.5%
A leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

A leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). DHR leads in 1 (Income & Cash Flow). 1 tied.

Best OverallAgilent Technologies, Inc. (A)Leads 4 of 6 categories
Loading custom metrics...

A vs DHR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is A or DHR a better buy right now?

For growth investors, Agilent Technologies, Inc.

(A) is the stronger pick with 6. 7% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Agilent Technologies, Inc. (A) offers the better valuation at 25. 8x trailing P/E (19. 7x forward), making it the more compelling value choice. Analysts rate Agilent Technologies, Inc. (A) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — A or DHR?

On trailing P/E, Agilent Technologies, Inc.

(A) is the cheapest at 25. 8x versus Danaher Corporation at 34. 7x. On forward P/E, Agilent Technologies, Inc. is actually cheaper at 19. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 34x versus Danaher Corporation's 34. 20x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — A or DHR?

Over the past 5 years, Agilent Technologies, Inc.

(A) delivered a total return of -7. 7%, compared to -20. 9% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: DHR returned +218. 0% versus A's +202. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — A or DHR?

By beta (market sensitivity over 5 years), Danaher Corporation (DHR) is the lower-risk stock at 0.

94β versus Agilent Technologies, Inc. 's 1. 23β — meaning A is approximately 31% more volatile than DHR relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 50% for Agilent Technologies, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — A or DHR?

By revenue growth (latest reported year), Agilent Technologies, Inc.

(A) is pulling ahead at 6. 7% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Agilent Technologies, Inc. grew EPS 3. 2% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, A leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — A or DHR?

Agilent Technologies, Inc.

(A) is the more profitable company, earning 18. 8% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: A leads at 21. 3% versus 20. 9% for DHR. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is A or DHR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 34x versus Danaher Corporation's 34. 20x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Agilent Technologies, Inc. (A) trades at 19. 7x forward P/E versus 20. 7x for Danaher Corporation — 1. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 41. 2% to $247. 00.

08

Which pays a better dividend — A or DHR?

All stocks in this comparison pay dividends.

Agilent Technologies, Inc. (A) offers the highest yield at 0. 8%, versus 0. 7% for Danaher Corporation (DHR).

09

Is A or DHR better for a retirement portfolio?

For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

94), 0. 7% yield, +218. 0% 10Y return). Both have compounded well over 10 years (DHR: +218. 0%, A: +202. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between A and DHR?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

A

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 10%
Run This Screen
Stocks Like

DHR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform A and DHR on the metrics below

Revenue Growth>
%
(A: 7.0% · DHR: 3.7%)
Net Margin>
%
(A: 18.3% · DHR: 14.9%)
P/E Ratio<
x
(A: 25.8x · DHR: 34.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.